Xconomy Boston

Dicerna Pharmaceuticals Garners $8,400,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cc4b138-0131-42dd-a220-b548acdfd631&Preview=1
Date
7/15/2008
Company Name
Dicerna Pharmaceuticals
Mailing Address
15 Peterson Circle Sudbury, MA 01776
Company Description
Dicerna Pharmaceuticals is a venture-backed startup developing novel therapeutics in multiple therapeutic areas based on Dicer substrate technology, which makes use of the RNA interference mechanism.
Website
http://www.dicerna.com
Transaction Type
Venture Equity
Transaction Amount
$8,400,000
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Abingworth Management Inc
Venture Investor
Oxford Bioscience Partners
Venture Investor
Skyline Ventures